Pharma & Biotech News #PharmaBuzz

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Weekly News Recap #Phispers

Moderna resolves vaccine patent dispute with Roivant, Arbutus; FDA grants accelerated approval to Ascendis' dwarfism therapy

Over the past week, tensions in the Middle East have escalated sharply after the US and Israel launched military strikes on Ira...

Impressions : 491

Gilead buys Arcellx for US$ 7.8 billion; FDA approves Vanda's antipsychotic pill for bipolar disorder, schizophrenia

In this week’s news, Gilead Sciences has entered into an agreement to acquire its cancer therapy partner Arcellx for US$ ...

Impressions : 633

FDA agrees to review Moderna's amended mRNA-based flu vaccine application; Lilly builds orforglipron stock ahead of approval

Last week, the US Food and Drug Administration (FDA) had said it will not review Moderna’s application for its experiment...

Impressions : 1518

FDA refuses to review Moderna's mRNA-based flu vaccine application; Lilly buys Orna for up to US$ 2.4 billion

The US Food and Drug Administration (FDA) has said it will not review Moderna’s application for its experimental influenz...

Impressions : 1524

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Moderna resolves vaccine patent dispute with Roivant, Arbutus; FDA grants accelerated approval to Ascendis' dwarfism therapy

Gilead buys Arcellx for US$ 7.8 billion; FDA approves Vanda's antipsychotic pill for bipolar disorder, schizophrenia

FDA agrees to review Moderna's amended mRNA-based flu vaccine application; Lilly builds orforglipron stock ahead of approval

FDA refuses to review Moderna's mRNA-based flu vaccine application; Lilly buys Orna for up to US$ 2.4 billion

Shandong New Time's Generics Brivaracetam Receives Approval in US

Zydus' Generics Ivermectin Receives Approval in US

Ajanta Pharma's Generics Empagliflozin Receives Approval in US

Rubin Research's Generics Cetirizine HCl Receives Approval in US

App's Generics Hydrocortisone Receives Approval in US

Dr Reddy's Generics Dexmedetomidine HCl Receives Approval in US

Eton Pharma's Desmoda Receives Approval in US

Eugia Pharma's Generics Everolimus Receives Approval in US

Natco's Generics Alectinib Receives Approval in US

Cipla's Generics Palbociclib Receives Approval in US

Harbin Jixianglong Biotech is on FDA Import Alert List

A. Nelson & Co.'s Receives FDA Warning Letter

FDA Issues Form 483 to Eugia Pharma Specialities Limited

FDA Issues Form 483 to Aurobindo Pharma Limited, Unit VII

Sitashree Laxminarayn Best Chiwdais is on FDA Import Alert List

Bertrand P Cole's Receives FDA Warning Letter

Cosmetic Manufacturers's Receives FDA Warning Letter

Yangzhou H&R Plastic Daily Chemical is on FDA Import Alert List

Foshan Miwei Cosmetics is on FDA Import Alert List

FDA Issues Form 483 to F.H. Investments Inc dba Asteria Health

Granules India's US packaging facility Passes FDA Inspection

J&J Secures Third FDA Approval For Multiple Myeloma Treatment

Sanofi Sells Generics Unit To Brazil's EMS

Lonza Shakes Off Capsule Business In $3B Deal With Lone Star

Servier Bolsters Brain Cancer Portfolio in $2.5B Day One Deal

Viking Therapeutics Joins Investor Conferences

INOVIO to Release Q4, FY 2025 Financials March 12

Amgen to Present at Leerink Partners Global Healthcare Conference

Sanofi Board Proposes Christel Heydemann As Independent Director

Iran war could disrupt India's pharma exports by up to $500M

Sanofi Sells Generics Unit To Brazil's EMS

China Approves Pfizer GLP-1 Drug for Weight Loss

Tevogen Advances Generics, Signs LOI with Apozeal Pharma

Merck KGAa Expects Mavenclad Generics To Deal Serious Blow In US

Glenmark Specialty SA Gets USFDA Nod For Fluticasone Propionate

Bayer's Pharma Division Sees One More Year of Declining Sales

Glenmark Pharmaceuticals Wins USFDA Nod For Fluticasone Inhaler

Breckenridge Launches Pomalidomide Capsules

Zydus Gets Final USFDA Nod For Ivermectin Tablets

Glenmark Set To Join Peers In 'Semaglutide' Push

J&J Secures Third FDA Approval For Multiple Myeloma Treatment

Lonza Shakes Off Capsule Business In $3B Deal With Lone Star

Servier Bolsters Brain Cancer Portfolio in $2.5B Day One Deal

INOVIO to Release Q4, FY 2025 Financials March 12

Zealand's Zupreme serves up to 10.7% mean weight loss

Daiichi pens Pact for High Cholesterol Digital Therapeutic

US FDA Approves Johnson & Johnson's Blood Cancer Drug

Genentech Announces Positive Phase II Results for Petrelintide

Tenaya, Alnylam Ink Collab to Find Gene Targets For Cardio Drugs

Merck KGaA drops pipeline asset from SpringWorks buyout

Esteve CDMO Launches $15.5M Chicago API Facility Expansion

Blue Jet Healthcare Initiates Rs. 2.3B Pharma Plant Construction

AbbVie Earmarks $380M for 2 new API plants

DoP Re-opens Online Submission For PLI Scheme For 2 Bulk Drugs

Aurobindo Pharma To Increase Pen-G Production Capacity To 10K MT

Maharashtra Sets Up 201 Bulk Drug Units in Konkan in 10 Years

Procurement Lessons From India's Pharma Sector

Fresenius, Phlow Link Up To Boost US Epinephrine Injection Supply

Lalitpur Bulk Drugs Park In UP Commences Phase-I With Approved

Sun Pharma To Pump In Rs 500 Cr In Assam Manufacturing Unit

FDA Cites Novo Nordisk Again For Misleading GLP-1 AD

BDCDA alerts fraternity about theft of Lantus SoloStar of Sanofi

Novo Earns FDA Untitled Letter For Apple-Inspired Ozempic Ad

FDA Rejection Letters Flag Data Concerns For AZ, GSK Biologics

Feinstein Institutes Research Uncovers Early Brain Signs

Icosapent Ethyl Reduces Hospitalization And Death Risk

Viatris To Cut 10% Of Workforce In 3-Year Overhaul

Drug Industry Groups And Combo Products Seek Clarity

FDA Intensifies Enforcement Against Non-Compliant Cough Syrup

Telangana's DCA Conducts Consecutive Raids Against Illegal Drug

Leo Roars Onto Netflix With DTC Campaign For New Eczema Cream

Women Respond Better To Cardiac Resynchronization Therapy

Biomerica Gets MHRA Approval For Hp+Detect Sales In Uk